(Q81601220)
Statements
Usefulness of enzyme-linked immunosorbent assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum (English)
Dimitrios Vassilopoulos
Nikolaos Stamoulis
Emilia Hadziyannis
Athanasios J Archimandritis